Results 111 to 120 of about 10,767 (163)

Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. [PDF]

Cancer
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA.   +20 more
europepmc   +1 more source

Mosaic <i>DICER1</i> RNase IIIb hotspot mutation with multiple tumors: case report and literature review. [PDF]

Front Oncol
Yang P, Jin M, Zhao W, Duan C, Yu J, Qu Y, Fu L, Yu T, Wang X, Guo R, Cui C, Mei D, Su Y.   +12 more
europepmc   +1 more source

Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors. [PDF]

Clin Cancer Res
Favours E, Tang H, Wong P, Ghilu S, Del Pozo V, Mironova E, Chen Y, Stearns T, Neuhauser S, Earley EJ, Erickson SW, Kwon JY, Jocoy EL, Groff D, Krytska K, Tsang M, Teicher BA, Mossé YP, Kolb EA, Hav M, Loo D, Houghton PJ, Bult CJ, Gorlick RG, Maris JM, Smith MA, Kurmasheva RT.   +26 more
europepmc   +1 more source

Denys-Drash Syndrome by <i>WT1</i> Gene: Clinical Variability and Management Challenges in Two Saudi Infants. [PDF]

Case Rep Endocrinol
Al-Amoudi W, Alhuthil R, Alnwiji A, Alqarni MS, Murad S, Alsagheir A.   +5 more
europepmc   +1 more source

AI-Assisted Preoperative Diagnosis of Wilms Tumor. [PDF]

Life (Basel)
Akay MA, Tatar OC, Tatar E, Demirsoy U, Anık Y, Yıldız GE, Varlıklı O.   +6 more
europepmc   +1 more source

BRAF V600E-mutated metastatic Wilms tumor with complete response to targeted RAF/MEK inhibition: a post-treatment follow-up case report. [PDF]

Front Oncol
Slika I, Edwards CK, Cohen KJ, Friedman AD, Pratilas CA, Odeniyide P.   +5 more
europepmc   +1 more source

Acquired von Willebrand syndrome in a patient with rectal adenocarcinoma: a case report and review of the literature. [PDF]

J Med Case Rep
De Polo S, Costanza M, Grandoni F, Alberio L, Tsilimidos G.   +4 more
europepmc   +1 more source

Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor. [PDF]

Front Oncol
Du H, Zheng Y, Zhu C, Guo Y, Li P, Hong P.   +5 more
europepmc   +1 more source

Genetic and Epigenetic Drivers of Wilms Tumor Predisposition in Russian Pediatric Patients: A Multicenter Study. [PDF]

Int J Mol Sci
Semenova V, Sagoyan G, Zhukovskaya E, Kozlova V, Gegelia N, Mitrofanova A, Suleymanova A, Druy A, Zelenova E, Pavlov V, Rubanskay M, Karelin A, Varfolomeeva S, Nasedkina T.   +13 more
europepmc   +1 more source